Advertisement

Topics

BioMarker Strategies Company Profile

23:00 EDT 23rd September 2017 | BioPortfolio

BioMarker Strategies (www.biomarkerstrategies.com) is a cancer diagnostics company that is developing a novel biomarker testing system to improve the treatment of cancer. SnapPath™ incorporates an automated and proprietary live-tumor-cell processing device with first-in-class, ex vivo biomarker tests to predict patient response to targeted cancer therapeutics, including drug combinations. In SnapPath™, live tumor cells obtained from fine needle aspiration and other biopsies are stimulated to generate a proprietary Functional Signaling Profile (FSP™) of the signal transduction network. Such functional profiles, which cannot be generated from fixed tissue, are the foundation for next-generation predictive tests for targeted therapy selection. The company, which is located at the Johns Hopkins Science + Technology Park in Baltimore, was named one of the “Top 20 Most Promising Startups in the U.S.” in 2010 by the Thomson-Reuters Venture Capital Journal. SnapPath™, which is supported with funding from the National Cancer Institute, is being designed as a platform for companion diagnostics to enable personalized medicine for patients with breast, lung, pancreatic, melanoma, colon and other solid-tumor based cancers.


News Articles [377 Associated News Articles listed on BioPortfolio]

STAT Plus: Biomarker

If it’s a function of, or it’s expressed in the human body and it can be measured, it can be a biomarker.

Biomarker May Help Monitor MPS Disease Progression

Researchers have identified spermine as a potential biomarker associated with neuropathic forms of mucopolysaccharidoses (MPS), a family of rare metabolic...

BioMarker Strategies Announces Issuance Of Key Patent In Europe Covering The Company???s Pathmap Functional Signaling Profile Technology

  Life Sciences Jobs   ...

BioMarker Strategies Announces Two New Patents Granted In Japan, Covering The Company???s Core Diagnostics Technologies For Solid Tumor Cancers

  Life Sciences Jobs   ...

FDA approves Merck’s Keytruda for patients who have a specific biomarker

Brian BerkAccording to the agency, this is the first time it has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated. read more

Approval for biomarker-based Keytruda a US FDA first

US FDA has approved a cancer treatment based on a common biomarker, as opposed to the location in the body where the tumour developed.

Biomarker Traces Glaucoma Development and Progression

A potential biomarker protein has been identified that was elevated in rodent models of glaucoma and in fluid taken from...

Biomarker May Identify High-risk IgAN Patients

Gd-IgA1 level may represent a useful biomarker for risk stratification.

Drugs and Medications [10 Associated Drugs and Medications listed on BioPortfolio]

Plavix [Rebel Distributors Corp]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

Plavix [Contract Pharmacy Services-PA]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

Plavix [State of Florida DOH Central Pharmacy]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

Plavix [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

Plavix [Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

PubMed Articles [1583 Associated PubMed Articles listed on BioPortfolio]

Placental exosomes as early biomarker of preeclampsia - Potential role of exosomal microRNAs across gestation.

There is a need to develop strategies for early prediction of patients who will develop preeclampsia (PE), in order to establish preventive strategies to reduce the prevalence and severity of the dise...

Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise.

Biomarker development in lupus nephritis (LN) has traditionally relied on comparing the characteristics of candidate markers to clinical findings in patients and controls from cross-sectional cohorts....

qFlow Cytometry-Based Receptoromic Screening: A High-Throughput Quantification Approach Informing Biomarker Selection and Nanosensor Development.

Nanosensor-based detection of biomarkers can improve medical diagnosis; however, a critical factor in nanosensor development is deciding which biomarker to target, as most diseases present several bio...

Phase II Cancer Clinical Trials for Biomarker-Guided Treatments.

The design and analysis of cancer clinical trials with biomarker depend on various factors, such as the phase of trials, the type of biomaker, whether the used biomarker is validated or not, and the s...

Biomarker Enrichment Considerations in Oncology Early Development Single Arm Studies.

Oncology drug development has been increasingly shaped by molecularly targeted agents (MTAs), which often demonstrate differential effectiveness driven by the biomarker expression levels on tumors. In...

Clinical Trials [2718 Associated Clinical Trials listed on BioPortfolio]

Evidence-based Screening Strategies for Celiac Disease

Main aim: To find evidence-based screening strategies for celiac disease in high risk groups and to find new biomarkers or biomarker combinations for celiac disease diagnostics and follow-...

Biomarker for Hurler Disease

Development of a new MS-based biomarker for the early and sensitive diagnosis of Hurler disease from plasma. Testing for clinical robustness, specificity and long-term stability of the bio...

Evaluating Strategies to Control Hypercholesterolemia

To determine the cost-effectiveness of alternative strategies for cholesterol reduction.

Guiding Evidence Based Therapy Using Biomarker Intensified Treatment

The primary objective is to determine the efficacy of a strategy of biomarker-guided therapy compared with usual care in high risk patients with left ventricular systolic dysfunction.

Biomarker for Mucolipidosis Disorder Type I, II, III or IV

Development of a new MS-based biomarker for the early and sensitive diagnosis of Mucolipidosis Disorder type I, II, III, IV disease from plasma. Testing for clinical robustness, specificit...

Companies [603 Associated Companies listed on BioPortfolio]

BioMarker Strategies, LLC

BioMarker Strategies has developed SnapPath®, the only cancer diagnostics system that automates and standardizes functional ex vivo profiling of live solid tumor cells from fre...

BioMarker Strategies

BioMarker Strategies (www.biomarkerstrategies.com) is a cancer diagnostics company that is developing a novel biomarker testing system to improve the treatment of cancer. SnapPath...

BiomarkerBase

BiomarkerBase™ (http://www.biomarkerbase.com) includes every molecular biomarker on a drug label, every biomarker in a PMA-approved diagnostic, prognostic, or companion diagn...

Glycemion Strategies, Inc.

Glycemion Strategies, Inc. provides marketing strategies to the pharmaceutical, functional food, nutraceutical and diagnostics industries.

Newport Strategies

Newport Strategies is the industry leader in the collection, validation, analysis and delivery of competitive intelligence concerning the development and manufacture of active pharmaceutical ingredien...

More Information about "BioMarker Strategies" on BioPortfolio

We have published hundreds of BioMarker Strategies news stories on BioPortfolio along with dozens of BioMarker Strategies Clinical Trials and PubMed Articles about BioMarker Strategies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMarker Strategies Companies in our database. You can also find out about relevant BioMarker Strategies Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record